Ixazomib is used in combination with lenalidomide and dexamethasone for the treatment of multiple myeloma in adults after at least one prior therapy. It is taken by mouth in form of capsules. Reference standards of Ixazomib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Ixazomib
Catalogue No.:PA 09 55000
CAS :
Molecular Formula : C14H19BCl2N2O4
Molecular Weight : 361.03
Ixazomib Citrate
Catalogue No.:PA 09 55510
Molecular Formula : C20H23BCl2N2O9
Molecular Weight : 517.12
4-(Carboxymethyl)-2-((R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-6-oxo-1,3,2-dioxaborinane-4-carboxylic Acid
Catalogue No.:PA 09 0551000
(2,5-Dichlorobenzoyl)glycine
Catalogue No.:PA 09 0551001
Molecular Formula : C9H7Cl2NO3
Molecular Weight : 248.06
2,5-Dichloro-N-(2-(isopentylamino)-2-oxoethyl)benzamide
Catalogue No.:PA 09 0551002
Molecular Formula : C14H18Cl2N2O2
Molecular Weight : 317.21
N-(2-Amino-2-oxoethyl)-2,5-dichlorobenzamide
Catalogue No.:PA 09 0551003
Molecular Formula : C9H8Cl2N2O2
Molecular Weight : 247.08
(R)-(1-(2,5-Dichlorobenzamido)-3-methylbutyl)boronic Acid
Catalogue No.:PA 09 0551004
Molecular Formula : C12H16BCl2NO3
Molecular Weight : 303.97
(R)-2,5-Dichloro-N-(2-((1-hydroxy-3-methylbutyl)amino)-2-oxoethyl)benzamide
Catalogue No.:PA 09 0551005
Molecular Formula : C14H18Cl2N2O3
Molecular Weight : 333.21
2,5-Dichloro-N-(2-(((R)-3-methyl-1-((3aS,4S,6S,7aR)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butyl)amino)-2-oxoethyl)benzamide
Catalogue No.:PA 09 0551006
Molecular Formula : C24H33BCl2N2O4
Molecular Weight : 495.25
Catalogue No.:PA 09 0551007
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
